Short course of clarithromycin in an immunocompetent patient with BCG-induced regional complications
Bacillus Calmette Guerin (BCG) has been used to vaccinate against tuberculosis since 1921. Persistant skin and lymph node lesions yielding Mycobacterium bovis are a rare complication for which there is not standardized treatment. We report an 11 month old child with a progressive cutaneous nodule an...
Gespeichert in:
| Veröffentlicht in: | Dermatology online journal 2002-10, Vol.8 (2), p.6-6 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 6 |
|---|---|
| container_issue | 2 |
| container_start_page | 6 |
| container_title | Dermatology online journal |
| container_volume | 8 |
| creator | Torres-Rojas, J R Rondón-Lugo, A Vidal, Rosa |
| description | Bacillus Calmette Guerin (BCG) has been used to vaccinate against tuberculosis since 1921. Persistant skin and lymph node lesions yielding Mycobacterium bovis are a rare complication for which there is not standardized treatment. We report an 11 month old child with a progressive cutaneous nodule and lymphadenopathy after BCG vaccination. These rapidly cleared with administration of clarithromycin. |
| doi_str_mv | 10.5070/D313T6G48B |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72835079</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72835079</sourcerecordid><originalsourceid>FETCH-LOGICAL-c200t-549dc3cc3fd666e4b2e2b09c9135ed6787b7dceb2fdce7f73f9c41da9336ac7c3</originalsourceid><addsrcrecordid>eNpNkM9LwzAYhoMobk4v_gGSkwehmh9t0h7d1CkMPDjPJf2Sukjb1KRF9t-bscGEj_f9Dg_v4UHompL7jEjy8MQpX4tlms9P0JSSXCYs5um_f4IuQvgmhJE04-doQlmWCinoFOmPjfMDBjf6YLCrMTTK22HjXbsF2-F4Kmbbjp0D1_ZmMN2AezXYXf9GEs8Xy8R2egSjsTdf1nWqwTu2sRA514VLdFarJpirQ8_Q58vzevGarN6Xb4vHVQKMkCHJ0kIDB-C1FkKYtGKGVaSAgvLMaCFzWUkNpmJ1TFlLXheQUq0KzoUCCXyGbve7vXc_owlD2doApmlUZ9wYSslyHo0VEbzbg-BdCN7UZe9tq_y2pKTcOS2PTiN8c1gdq9boI3qQyP8ADXR0Aw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72835079</pqid></control><display><type>article</type><title>Short course of clarithromycin in an immunocompetent patient with BCG-induced regional complications</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Torres-Rojas, J R ; Rondón-Lugo, A ; Vidal, Rosa</creator><creatorcontrib>Torres-Rojas, J R ; Rondón-Lugo, A ; Vidal, Rosa</creatorcontrib><description>Bacillus Calmette Guerin (BCG) has been used to vaccinate against tuberculosis since 1921. Persistant skin and lymph node lesions yielding Mycobacterium bovis are a rare complication for which there is not standardized treatment. We report an 11 month old child with a progressive cutaneous nodule and lymphadenopathy after BCG vaccination. These rapidly cleared with administration of clarithromycin.</description><identifier>ISSN: 1087-2108</identifier><identifier>EISSN: 1087-2108</identifier><identifier>DOI: 10.5070/D313T6G48B</identifier><identifier>PMID: 12546761</identifier><language>eng</language><publisher>United States</publisher><subject>Administration, Oral ; BCG Vaccine - adverse effects ; BCG Vaccine - therapeutic use ; Clarithromycin - administration & dosage ; Clarithromycin - therapeutic use ; Drug Administration Schedule ; Female ; Humans ; Immunocompetence ; Infant ; Lymphatic Diseases - drug therapy ; Lymphatic Diseases - etiology ; Lymphatic Diseases - microbiology ; Mycobacterium bovis - immunology ; Mycobacterium bovis - isolation & purification ; Mycobacterium bovis - pathogenicity ; Skin Diseases - drug therapy ; Skin Diseases - etiology ; Skin Diseases - microbiology ; Tuberculosis - prevention & control</subject><ispartof>Dermatology online journal, 2002-10, Vol.8 (2), p.6-6</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c200t-549dc3cc3fd666e4b2e2b09c9135ed6787b7dceb2fdce7f73f9c41da9336ac7c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12546761$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Torres-Rojas, J R</creatorcontrib><creatorcontrib>Rondón-Lugo, A</creatorcontrib><creatorcontrib>Vidal, Rosa</creatorcontrib><title>Short course of clarithromycin in an immunocompetent patient with BCG-induced regional complications</title><title>Dermatology online journal</title><addtitle>Dermatol Online J</addtitle><description>Bacillus Calmette Guerin (BCG) has been used to vaccinate against tuberculosis since 1921. Persistant skin and lymph node lesions yielding Mycobacterium bovis are a rare complication for which there is not standardized treatment. We report an 11 month old child with a progressive cutaneous nodule and lymphadenopathy after BCG vaccination. These rapidly cleared with administration of clarithromycin.</description><subject>Administration, Oral</subject><subject>BCG Vaccine - adverse effects</subject><subject>BCG Vaccine - therapeutic use</subject><subject>Clarithromycin - administration & dosage</subject><subject>Clarithromycin - therapeutic use</subject><subject>Drug Administration Schedule</subject><subject>Female</subject><subject>Humans</subject><subject>Immunocompetence</subject><subject>Infant</subject><subject>Lymphatic Diseases - drug therapy</subject><subject>Lymphatic Diseases - etiology</subject><subject>Lymphatic Diseases - microbiology</subject><subject>Mycobacterium bovis - immunology</subject><subject>Mycobacterium bovis - isolation & purification</subject><subject>Mycobacterium bovis - pathogenicity</subject><subject>Skin Diseases - drug therapy</subject><subject>Skin Diseases - etiology</subject><subject>Skin Diseases - microbiology</subject><subject>Tuberculosis - prevention & control</subject><issn>1087-2108</issn><issn>1087-2108</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkM9LwzAYhoMobk4v_gGSkwehmh9t0h7d1CkMPDjPJf2Sukjb1KRF9t-bscGEj_f9Dg_v4UHompL7jEjy8MQpX4tlms9P0JSSXCYs5um_f4IuQvgmhJE04-doQlmWCinoFOmPjfMDBjf6YLCrMTTK22HjXbsF2-F4Kmbbjp0D1_ZmMN2AezXYXf9GEs8Xy8R2egSjsTdf1nWqwTu2sRA514VLdFarJpirQ8_Q58vzevGarN6Xb4vHVQKMkCHJ0kIDB-C1FkKYtGKGVaSAgvLMaCFzWUkNpmJ1TFlLXheQUq0KzoUCCXyGbve7vXc_owlD2doApmlUZ9wYSslyHo0VEbzbg-BdCN7UZe9tq_y2pKTcOS2PTiN8c1gdq9boI3qQyP8ADXR0Aw</recordid><startdate>200210</startdate><enddate>200210</enddate><creator>Torres-Rojas, J R</creator><creator>Rondón-Lugo, A</creator><creator>Vidal, Rosa</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200210</creationdate><title>Short course of clarithromycin in an immunocompetent patient with BCG-induced regional complications</title><author>Torres-Rojas, J R ; Rondón-Lugo, A ; Vidal, Rosa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c200t-549dc3cc3fd666e4b2e2b09c9135ed6787b7dceb2fdce7f73f9c41da9336ac7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Administration, Oral</topic><topic>BCG Vaccine - adverse effects</topic><topic>BCG Vaccine - therapeutic use</topic><topic>Clarithromycin - administration & dosage</topic><topic>Clarithromycin - therapeutic use</topic><topic>Drug Administration Schedule</topic><topic>Female</topic><topic>Humans</topic><topic>Immunocompetence</topic><topic>Infant</topic><topic>Lymphatic Diseases - drug therapy</topic><topic>Lymphatic Diseases - etiology</topic><topic>Lymphatic Diseases - microbiology</topic><topic>Mycobacterium bovis - immunology</topic><topic>Mycobacterium bovis - isolation & purification</topic><topic>Mycobacterium bovis - pathogenicity</topic><topic>Skin Diseases - drug therapy</topic><topic>Skin Diseases - etiology</topic><topic>Skin Diseases - microbiology</topic><topic>Tuberculosis - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Torres-Rojas, J R</creatorcontrib><creatorcontrib>Rondón-Lugo, A</creatorcontrib><creatorcontrib>Vidal, Rosa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Dermatology online journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Torres-Rojas, J R</au><au>Rondón-Lugo, A</au><au>Vidal, Rosa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Short course of clarithromycin in an immunocompetent patient with BCG-induced regional complications</atitle><jtitle>Dermatology online journal</jtitle><addtitle>Dermatol Online J</addtitle><date>2002-10</date><risdate>2002</risdate><volume>8</volume><issue>2</issue><spage>6</spage><epage>6</epage><pages>6-6</pages><issn>1087-2108</issn><eissn>1087-2108</eissn><abstract>Bacillus Calmette Guerin (BCG) has been used to vaccinate against tuberculosis since 1921. Persistant skin and lymph node lesions yielding Mycobacterium bovis are a rare complication for which there is not standardized treatment. We report an 11 month old child with a progressive cutaneous nodule and lymphadenopathy after BCG vaccination. These rapidly cleared with administration of clarithromycin.</abstract><cop>United States</cop><pmid>12546761</pmid><doi>10.5070/D313T6G48B</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1087-2108 |
| ispartof | Dermatology online journal, 2002-10, Vol.8 (2), p.6-6 |
| issn | 1087-2108 1087-2108 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72835079 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Administration, Oral BCG Vaccine - adverse effects BCG Vaccine - therapeutic use Clarithromycin - administration & dosage Clarithromycin - therapeutic use Drug Administration Schedule Female Humans Immunocompetence Infant Lymphatic Diseases - drug therapy Lymphatic Diseases - etiology Lymphatic Diseases - microbiology Mycobacterium bovis - immunology Mycobacterium bovis - isolation & purification Mycobacterium bovis - pathogenicity Skin Diseases - drug therapy Skin Diseases - etiology Skin Diseases - microbiology Tuberculosis - prevention & control |
| title | Short course of clarithromycin in an immunocompetent patient with BCG-induced regional complications |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T18%3A08%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Short%20course%20of%20clarithromycin%20in%20an%20immunocompetent%20patient%20with%20BCG-induced%20regional%20complications&rft.jtitle=Dermatology%20online%20journal&rft.au=Torres-Rojas,%20J%20R&rft.date=2002-10&rft.volume=8&rft.issue=2&rft.spage=6&rft.epage=6&rft.pages=6-6&rft.issn=1087-2108&rft.eissn=1087-2108&rft_id=info:doi/10.5070/D313T6G48B&rft_dat=%3Cproquest_cross%3E72835079%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72835079&rft_id=info:pmid/12546761&rfr_iscdi=true |